Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients

Published:2020-10-12 Issue:12 Volume:19 Page:1617-1624
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Giraud Eline L.¹^ORCID,Jessurun Naomi T.¹^ORCID,van Hunsel Florence P.A.M.¹^ORCID,van Puijenbroek Eugene P.¹^ORCID,van Tubergen Astrid²^ORCID,Ten Klooster Peter M.³⁴^ORCID,Vonkeman Harald E.⁴⁵^ORCID

Affiliation:

1. Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The Netherlands

2. Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, the Netherlands and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands

3. Transparency in Healthcare B.v., Hengelo, The Netherlands

4. Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands

5. Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands

Funder

No sources of funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1830058

Reference39 articles.

1. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

3. Managing the drug treatment of rheumatoid arthritis

4. Guideline A. On Summary Of Product Characteristics (SmPC). 2009. (Directorate-General ECEAI, editor). p. 29.

5. DREAM-RA registry. 2020. [cited 2020 May 1]. Available from: https://www.dreamregistry.nl

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDENTIFICATION OF IMMUNE RESPONSE AND RNA NETWORK OF RHEUMATOID ARTHRITIS AND MOLECULAR DOCKING OFCELASTRUS PANICULATUSAS POTENTIAL THERAPEUTIC AGENT;2024-08-01

2. The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept;Expert Opinion on Drug Safety;2024-07-26

3. Multiple Sclerosis Risk Among Anti-tumor Necrosis Factor Alpha Users: A Methodological Review of Observational Studies Based on Real-world Data;Current Drug Safety;2024-05

4. The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995–2015);Rheumatology International;2024-04-14

5. Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry;Journal of the European Academy of Dermatology and Venereology;2023-11-29